Robin Ince just asked if I know any epidemiologist lightbulb jokes. I wrote this for him. How many epidemiologists does it take to change a lightbulb? We’ve found 12,000 switches hidden around the house. Some of them turn this lightbulb on, some of them don’t; some of them only work sometimes; and some of them […]
среда, 1 февраля 2017 г.
вторник, 11 октября 2016 г.
“Transparency, Beyond Publication Bias”. A video of my super-speedy talk at IJE
People often talk about “trials transparency” as if this means “all trials must be published in an academic journal”. In reality, true transparency goes much further than this. We need Clinical Study Reports, and individual patient data, of course. But we also need the consent forms, so we can see what patients were told. We need […]
пятница, 7 октября 2016 г.
You should totally watch this entire day of the IJE conference
Today marks the end of an era. The International Journal of Epidemiology used to be a typical hotchpotch of isolated papers on worthy subjects. Occasionally, some were interesting, or related to your field. Under Shah Ebrahim and George Davey-Smith it became like nothing else: an epidemiology journal you’d happily subscribe to with your own money, and read in […]
понедельник, 3 октября 2016 г.
An audio interview with The Conversation, on smashing the walls of the Ivory Tower
The Conversation is a great media outlet, because it’s run by academic nerds, but made for everyone. I had a nice time chatting with them last week: we discussed transparency, data sharing, statins, research integrity, risk communication, culture shift, academic activism, and why we should kick through the walls of the ivory tower. Caution: contains nerds! theconversation.com/speaking-with-bad-pharma-author-ben-goldacre-about-how-bad-research-hurts-us-all-65800
пятница, 30 сентября 2016 г.
Sarepta, eteplirsen: anecdote, data, surrogate outcomes, and the FDA
The Duchenne’s treatment made by Sarepta (eteplirsen) has been in the news this week, as a troubling example of the FDA lowering its bar for approval of new medicines. The FDA expert advisory panel decided not to approve this treatment, because the evidence for any benefit is weak; but there was extensive lobbying from well-organised patients and, eventually, the FDA overturned the opinion of its own […]
среда, 28 сентября 2016 г.
The Cancer Drugs Fund is producing dangerous, bad data: randomise everyone, everywhere!
There are recurring howls in my work. One of them is this: in general, if you don’t know which intervention works best, then you should randomise everyone, everywhere. This is for good reason: uncertainty costs lives, through sub-optimal treatment. Wherever randomised trials are the right approach, you should embed them in routine clinical care. This is an argument I’ve made, with colleagues, in […]
четверг, 22 сентября 2016 г.
Taking transparency beyond results: ethics committees must work in the open
Here’s a useful paper we’ve just published in the BMJ, documenting problems in transparency around approval processes for randomised trials. There’s a basic rule in clinical research: you’re only supposed to do a trial comparing two treatments when you really don’t know which one is best, otherwise you’d be knowingly randomising half your participants to an […]
Events in Sydney, Melbourne, Brisbane, Auckland
Hi there, I’m doing a few events in Australia and NZ this week: in Sydney, Melbourne, Auckland (only 25 tickets left), and Brisbane. Here‘s a good fun interview I did with The Conversation that gets very nerdy, on the poor state of science, COMPare, statins, reproducibility and transparency. I’ll post a big backlog of interviews, and papers, over […]
пятница, 14 августа 2015 г.
So this company Cyagen is paying authors for citations in academic papers
Here’s a strange thing, a seedy curio rather than a massive scandal, but I’d be interested to know what you make of it. This week lots of academics all received the same unsolicited marketing email from a large well known research company called Cyagen, who make transgenic mice, stem cells, and so on. The email was headed […]
пятница, 10 июля 2015 г.
Fixing flaws in science must be professionalised. By me in the Journal of Clinical Epidemiology
Me and a dozen other academics all just wrote basically the same thing about Open Science in the Journal Of Clinical Epidemiology. After the technical bits, me and Tracey get our tank out. That’s for a reason: publishing academic papers about structural problems in science is a necessary condition for change, but it’s not sufficient. We don’t need any […]
вторник, 23 июня 2015 г.
New BMJ editorial: “How Medicine is Broken, and How We Can Fix It”
There are some big problems in medicine, and the public are right to be concerned about our shortcomings. Last week we found out that the Chief Medical Officer has written to the Academy of Medical Sciences, asking for an authoritative review into problems in the evidence we use to choose treatments, focusing especially on concerns […]
четверг, 16 апреля 2015 г.
WHO announcement on withheld clinical trials, and my commentary in PLoS Medicine
As you’ll hopefully know by now from reading Bad Science, Bad Pharma, and my endless columns on the subject, medicine has a problem: the results of clinical trials are routinely and legally withheld from doctors, researchers, and patients. We started the AllTrials.net campaign two years ago to build a global campaign on this issue, and we’ll be publishing […]
среда, 10 декабря 2014 г.
My BMJ editorial: how can we stop academic press releases misleading the public?
There is an excellent research paper published today in the BMJ, showing that academic press releases routinely exaggerate scientific findings and mislead the public. This is something I’ve often covered. In this story, for example, the BMJ’s own press release about their own paper was hopelessly and entirely misleading. And after this story, featuring a […]
среда, 19 ноября 2014 г.
That YouGov parlour game is wrong. This annoys me
YouGov have produced a fun, popular new parlour game. You give the site the name of a celebrity, author, TV show, pet, activity, or anything; and it gives you a lot more information in return. Essentially: “other things that such a person typically does and likes”. So, the “favourite dishes” of people who read Ben Goldacre books are Vegetarian Thali, […]
пятница, 14 ноября 2014 г.
Some London talks and events coming up
There are a few London talks and events coming up over the next few weeks, all very different, and more to come around the country soon: Monday 17th Nov – Richard Herring Leicester Square Podcast This show is a great institution: comedian Richard Herring interviews comedians and the occasional nerd in front of a live audience, […]
среда, 5 ноября 2014 г.
What should Cochrane do next?
Here’s a talk I did last year that’s just popped up online. The Cochrane Collaboration is a fabulous organisation, producing gold standard “systematic reviews” summarising all the data that’s ever been collected on important questions in medicine. Cochrane have become great by inviting criticism: for example, they run the Silverman Prize, for the best essay or paper pointing […]